* Outset Medical Inc OM.OQ reported a quarterly adjusted
loss
of 85 cents per share for the quarter ended in September. The
mean expectation of six analysts for the quarter was for a loss
of 81 cents per share.
* Revenue rose 5.5% to $27.76 million from a year ago;
analysts
expected $25.22 million.
* Outset Medical Inc's reported EPS for the quarter was a
loss
of 85 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Outset Medical Inc shares had fallen by 22.2% this
quarter and
lost 73.1% so far this year.
* The company reported a quarterly loss of $40.78 million.
* Wall Street's median 12-month price target for Outset
Medical
Inc is $27.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
8 at 10:02 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.81 -0.85 Missed
Jun. 30 2022 -0.70 -0.92 Missed
Mar. 31 2022 -0.72 -0.78 Missed
Dec. 31 2021 -0.77 -0.87 Missed